A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antihypertensive efficacy and safety of
Fimasartan/Hydrochlorothiazide combination 60/12.5mg~120/12.5mg in patients with essential
hypertension who are not controlled by fimasartan 60mg.
Phase:
Phase 3
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Collaborators:
Ajou University Asan Medical Center Cheil General Hospital and Women's Healthcare Center Cheil General Hospital and Women’s Healthcare Center Chonbuk National University Hospital Chonnam National University Hospital DongGuk University Gangnam Severance Hospital Hanyang University Ilsan-Paik Hospital Korea University Guro Hospital Kyung Hee University Hospital Kyung-Hee University Hospital Samsung Medical Center Seoul National University Bundang Hospital Seoul National University Hospital Severance Hospital SMG-SNU Boramae Medical Center The Catholic University of Korea Yonsei University